A Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDS

ABSTRACT: A Phase I Pharmacologic Study of CYC140, a polo-like kinase 1 inhibitor, in Patients with Advanced Leukemias or Myelodysplastic Syndromes

DISEASE(S): Myelodysplastic Syndromes,Metastatic Colorectal Cancer,Gallbladder Carcinoma,Intrahepatic Cholangiocarcinoma,B-cell Lymphoma,Extrahepatic Cholangiocarcinoma,Leukemia,Small Cell Lung Cancer,Preleukemia,Bladder Cancer,Cml, Refractory,Cll, Refractory,Breast Cancer,All, Adult,Advanced Solid Tumors And Lymphoma,Non-small Cell Lung Cancer,Tumores Sólidos Y Linfomas Avanzados,Aml, Adult,Hepatocellular Carcinoma

PROVIDER: 2300557 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR